Endovascular treatment increases but gamma knife radiosurgery recreases angiogenic activity of arteriovenous malformations: An in vivo experimental study using a rat cornea model

Neurosurgery

Volumn 66, Issue 1, 2010, Pages 121-129

  Akakin, Akin ^a   Ozkan, Abdulkadir ^a   Akgun, Emel ^a   Koc, Demet Yalcinkaya ^a   Konya, Deniz ^a   Pamir, M Necmettin ^a   Kilic, Turker ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Arteriovenous malformation; Cornea angiogenesis model; Embolization; Endovascular treatment; Gamma knife radiosurgery

Indexed keywords

VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ARTERIOVENOUS MALFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; MICROVASCULATURE; NONHUMAN; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ADOLESCENT; ADULT; ANIMALS; ARTERIOVENOUS MALFORMATIONS; BLOOD VESSELS; CEREBRAL ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; CORNEA; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RADIOSURGERY; RATS; RATS, SPRAGUE-DAWLEY; RETROSPECTIVE STUDIES; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 77249120073     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000363154.88768.34     Document Type: Article

References (46)

1. Deniz ML, Kilic T, Almaata I, Kurtkaya O, Sav A, Pamir MN. Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor ?, and fibronectin are correlated with recurrence. Neurosurgery. 2002;51(3):753-760; discussion 760.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182-1186.
3. Kilic T, Alberta JA, Zdunek PR, et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 2000;60(18):5143-5150.
4. Kilic T, Bayri Y, Ozduman K, et al. Tenascin in meningioma: expression is correlated with anaplasia, vascular endothelial growth factor expression, and peritumoral edema but not with tumor border shape. Neurosurgery. 2002;51(1):183-192; discussion 192-193.
5. Kilic T, Sohrabifar M, Kurtkaya O, et al. Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery. 2005;57(5):997-1006; discussion 1006-1007.
6. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-936.
7. Harrigan MR. Angiogenic factors in the central nervous system. Neurosurgery. 2003;53(3):639-660; discussion 660-661.
8. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PMcL. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery. 2000;46(5):1179-1191; discussion 1191-1192.
9. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery. 1996;38(5):915-924; discussion 924-925.
10. Hashimoto T, Lawton MT, Wen G, et al. Gene microarray analysis of human brain arteriovenous malformations. Neurosurgery. 2004;54(2):410-423; discussion 423-425.
11. Shenkar R, Elliott JP, Diener K, et al. Differential gene expression in human cerebrovascular malformations. Neurosurgery. 2003;52(2):465-477; discussion 477-478.
12. Konya D, Yildirim O, Kurtkaya O, et al. Testing the angiogenic potential of cerebrovascular malformations by use of a rat cornea model: usefulness and novel assessment of changes over time. Neurosurgery. 2005;56(6):1339-1345; discussion 1345-1346.
13. Kilic K, Konya D, Kurtkaya O, Sav A, Pamir MN, Kilic T. Inhibition of angiogenesis induced by cerebral arteriovenous malformations using gamma knife irradiation. J Neurosurg. 2007;106(3):463-469.
14. Hashimoto N, Nozaki K. Do cerebral arteriovenous malformations recur after angiographically confirmed total extirpation? Crit Rev Neurosurg. 1999;9(3):141-146.
15. Kader A, Goodrich JT, Sonstein WJ, Stein BM, Carmel PW, Michelsen WJ. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. J Neurosurg. 1996;85(1):14-18.
16. Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery. 2004;55(1):1-16; discussion 16-17.
17. Hashimoto T, Emala CW, Joshi S, et al. Abnormal pattern of Tie-2 and vascular endothelial growth factor receptor expression in human cerebral arteriovenous malformations. Neurosurgery. 2000;47(4):910-918; discussion 918-919.
18. Hashimoto T, Mesa-Tejada R, Quick CM, et al. Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery. 2001;49(1):124- 131; discussion 131-132.
19. Zadeh G, Guha A. Angiogenesis in nervous system disorders. Neurosurgery. 2003;53(6):1362-1374; discussion 1374-1376.
20. Seker A, Yildirim O, Kurtkaya O, et al. Expression of integrins in cerebral arteriovenous and cavernous malformations. Neurosurgery. 2006;58(1):159-168; discussion 159-168.
21. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389-395.
22. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407(6801):249-257.
23. Chen Y, Pawlikowska L, Yao JS, et al. Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol. 2006;59(1):72-80.
24. Sonstein WJ, Kader A, Michelsen WJ, Llena JF, Hirano A, Casper D. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study. J Neurosurg. 1996;85(5):838-845.
25. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery. 2001;48(2):359-367; discussion 367-368.
26. Hashimoto T, Wen G, Lawton MT, et al Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke. 2003;34(4):925-931.
27. Akimoto H, Komatsu K, Kubota Y. Symptomatic de novo arteriovenous malformation appearing 17 years after the resection of two other arteriovenous malformations in childhood: case report. Neurosurgery. 2003;52(1):228-231; discussion 231-232.
28. Ali MJ, Bendok BR, Rosenblatt S, Rose JE, Getch CC, Batjer HH. Recurrence of pediatric cerebral arteriovenous malformations after angiographically documented resection. Pediatr Neurosurg. 2003;39(1):32-38.
29. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359 (9309):863-873.
30. Freudenstein D, Duffner F, Ernemann U, Rachinger J, Grote E. Recurrence of a cerebral arteriovenous malformation after surgical excision. Cerebrovasc Dis. 2001;11(1):59-64.
31. Gabriel EM, Sampson JH, Wilkins RH. Recurrence of a cerebral arteriovenous malformation after surgical excision. Case report. J Neurosurg. 1996;84(5):879-882.
32. Rodriguez-Arias C, Martinez R, Rey G, Bravo G. Recurrence in a different location of a cerebral arteriovenous malformation in a child after radiosurgery. Childs Nerv Syst. 2000;16(6):363-365.
33. Santoro A, Giuliani S, Paolini S. Recurrent arteriovenous malformation in an adult. Case illustration. J Neurosurg. 2000;93(6):1082.
34. Mullan S. Reflections upon the nature and management of intracranial and intraspinal vascular malformations and fistulae. J Neurosurg. 1994;80(4):606-616.
35. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery. 2002;50(1):117-124; discussion 124-126.
36. Alexander MJ, DeSalles AA, Tomiyasu U. Multiple radiation-induced intracranial lesions after treatment for pituitary adenoma. Case report. J Neurosurg. 1998;88(1):111-115.
37. Fiorella D, Albuquerque FC, Woo HH, McDougall CG, Rasmussen PA. The role of neuroendovascular therapy for the treatment of brain arteriovenous malformations. Neurosurgery. 2006;59(5 Suppl 3):S163-S177; discussion S3-S13.
38. Alexander MJ, Tolbert ME. Targeting cerebral arteriovenous malformations for minimally invasive therapy. Neurosurgery. 2006;59(5 Suppl 3):S178-S183; discussion S3-S13.
39. Standard SC, Guterman LR, Chavis TD, Hopkins LN. Delayed recanalization of a cerebral arteriovenous malformation following angiographic obliteration with polyvinyl alcohol embolization. Surg Neurol. 1995;44(2):109-112; discussion 112-113.
40. Sure U, Butz N, Schlegel J, et al. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg. 2001;94(6):972-977.
41. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H. Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg. 2001;103(1):29-32.
42. Sure U, Battenberg E, Dempfle A, Tirakotai W, Bien S, Bertalanffy H. Hypoxiainducible factor and vascular endothelial growth factor are expressed more frequently in embolized than in nonembolized cerebral arteriovenous malformations. Neurosurgery. 2004;55(3):663-669; discussion 669-670.
43. Andrade-Souza YM, Ramani M, Scora D, Tsao MN, ter Brugge K, Schwartz ML. Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations. Neurosurgery. 2007;60(3):443-451; discussion 451-452.
44. Miyawaki L, Dowd C, Wara W, et al. Five year results of LINAC radiosurgery for arteriovenous malformations: outcome for large AVMS. Int J Radiat Oncol Biol Phys. 1999;44(5):1089-1106.
45. Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery. 1998;42(6):1239-1244; discussion 1244-1247.
46. Schlienger M, Atlan D, Lefkopoulos D, et al. Linac radiosurgery for cerebral arteriovenous malformations: results in 169 patients. Int J Radiat Oncol Biol Phys. 2000;46(15):1135-1142.